Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENV-294 in Moderate-to-Severe Asthma
NCT07301255Phase 2Recruiting
- Sponsor
- Enveda Biosciences
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ENV-294 in asthma, sponsored by Enveda Biosciences. Started Jan 2026; status: recruiting.
02
Drugs
ENV-294
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07301255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07301255.